165 related articles for article (PubMed ID: 8738829)
1. Clinical trials referral resource. Clinical trials using bryostatin-1.
Pluda JM; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 May; 10(5):740-2. PubMed ID: 8738829
[No Abstract] [Full Text] [Related]
2. Clinical trials referral resource. Clinical trials with arsenic trioxide.
Murgo AJ; McBee WL; Cheson BD
Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
[No Abstract] [Full Text] [Related]
3. Clinical trials referral resource. Clinical trials of suramin.
Cheson BD; Phillips PH; Pluda JM; Christian M
Oncology (Williston Park); 1995 Feb; 9(2):161, 163. PubMed ID: 8771098
[No Abstract] [Full Text] [Related]
4. The clinical development of the bryostatins.
Clamp A; Jayson GC
Anticancer Drugs; 2002 Aug; 13(7):673-83. PubMed ID: 12187323
[TBL] [Abstract][Full Text] [Related]
5. The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro.
Gebbia V; Citarrella P; Miserendino V; Valenza R; Borsellino N; Pesta A; Pettit R; May S
Tumori; 1992 Jun; 78(3):167-71. PubMed ID: 1440938
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Varterasian ML; Mohammad RM; Shurafa MS; Hulburd K; Pemberton PA; Rodriguez DH; Spadoni V; Eilender DS; Murgo A; Wall N; Dan M; Al-Katib AM
Clin Cancer Res; 2000 Mar; 6(3):825-8. PubMed ID: 10741703
[TBL] [Abstract][Full Text] [Related]
7. Bryostatin 1: will the oceans provide a cancer cure?
Kraft AS
J Natl Cancer Inst; 1993 Nov; 85(22):1790-2. PubMed ID: 8230254
[No Abstract] [Full Text] [Related]
8. A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.
Weitman S; Langevin AM; Berkow RL; Thomas PJ; Hurwitz CA; Kraft AS; Dubowy RL; Smith DL; Bernstein M
Clin Cancer Res; 1999 Sep; 5(9):2344-8. PubMed ID: 10499603
[TBL] [Abstract][Full Text] [Related]
9. Morbilliform drug reaction with histologic features of pustular dermatosis associated with bryostatin-1.
Krejci-Manwaring JM; Bogle MA; Diwan HA; Duvic MA
J Drugs Dermatol; 2003 Oct; 2(5):557-61. PubMed ID: 14558406
[TBL] [Abstract][Full Text] [Related]
10. Phase Ib trial of bryostatin 1 in patients with refractory malignancies.
Grant S; Roberts J; Poplin E; Tombes MB; Kyle B; Welch D; Carr M; Bear HD
Clin Cancer Res; 1998 Mar; 4(3):611-8. PubMed ID: 9533528
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials referral resource.
Wright JJ; Zerivitz K; Gravell A
Oncology (Williston Park); 2005 May; 19(6):722, 725-6, 728 passim. PubMed ID: 15971449
[No Abstract] [Full Text] [Related]
12. Clinical trials referral resource. Current clinical trials of bortezomib.
Wright JJ; Zerivitz K; Schoenfeldt M
Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
[No Abstract] [Full Text] [Related]
13. Bryostatin-I: an antineoplastic treasure from the deep?
May WS; Ruvolo PP
Cancer Biol Ther; 2002; 1(4):417-9. PubMed ID: 12432258
[No Abstract] [Full Text] [Related]
14. Treatment of patients with metastatic melanoma with bryostatin-1--a phase II study.
Gonzalez R; Ebbinghaus S; Henthorn TK; Miller D; Kraft AS
Melanoma Res; 1999 Dec; 9(6):599-606. PubMed ID: 10661772
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of bryostatin 1 in metastatic malignant melanoma.
Propper DJ; Macaulay V; O'Byrne KJ; Braybrooke JP; Wilner SM; Ganesan TS; Talbot DC; Harris AL
Br J Cancer; 1998 Nov; 78(10):1337-41. PubMed ID: 9823975
[TBL] [Abstract][Full Text] [Related]
16. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
17. Chemistry and clinical biology of the bryostatins.
Mutter R; Wills M
Bioorg Med Chem; 2000 Aug; 8(8):1841-60. PubMed ID: 11003129
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials referral resource. Clinical trials using edatrexate.
Cheson BD; Sorenson JM; Phillips PH
Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
[No Abstract] [Full Text] [Related]
19. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Cheson BD
Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
[No Abstract] [Full Text] [Related]
20. Clinical trials refferal resource. Current clinical trials of new agents and novel therapies in pediatric leukemia and lymphoma.
Smith MA; Schoenfeldt M
Oncology (Williston Park); 2003 Oct; 17(10):1377, 1380, 1383-4. PubMed ID: 14606363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
